A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Conference Coverage
Acupuncture Reduces Pain after Neck Dissection

According to the results of a study presented at the 2008 annual meeting of the American Society of Clinical Oncology, acupuncture is more effective than usual care in reducing pain and dysfunction following neck dissection for head and neck cancer.1

Head and neck cancers include cancers of the oral cavity, nasal cavity, paranasal sinuses, pharynx, and larynx. Depending on the location and stage of the cancer, treatment may involve surgery, radiation therapy, chemotherapy, targeted therapy, or a combination of these approaches. Neck dissection involves surgical removal of lymph nodes and other tissue from the neck, and may be performed to treat cancer that has spread to the lymph nodes.

In a previous small randomized study of acupuncture, 38 patients with radiation-induced xerostomia were randomized to classical accupunture (n=20) or superficial acupuncture as placebo (n=18). Among those patients who had had all their salivary glands irradiated, 50% in both groups showed increased salivary flow rates (>20%) by the end of the observation period of one year.2

To evaluate the ability of acupuncture to reduce pain and dysfunction following a neck dissection, researchers conducted a study among 70 patients who had had a neck dissection at least three months previously, and who were experiencing pain and/or dysfunction (Constant-Murley score<70) as a result of the neck dissection.

Patients were assigned to receive either weekly acupuncture or usual care. Usual care involved treatments such as pain medications and physical therapy.

  • A response to treatment (defined as at least a 33% improvement in Constant-Murley score) was experienced by 39% of the patients in the acupuncture group versus 7% of patients in the usual care group.
  • Patients treated with acupuncture were also more likely to report an improvement in xerostomia.

Comments: Although these results will need to be confirmed in additional studies, they suggest that acupuncture may be useful in managing pain and dysfunction in patients with head and neck cancer.

Reference: 


1 Pfister D, Vickers A, Deng G et al. Acupuncture for pain and dysfunction after neck dissection: preliminary results of a randomized controlled trial. Proceedings from the 44th annual meeting of the American Society of Clinical Oncology. Chicago, IL. 2008. Abstract #6016.

2 Blom M, Dawidson I, Fernberg JO, Johnson G, et al. Acupuncture treatment of patients with radiation-induced xerostomia. Eur J Cancer B Oral Oncol. 1996 May;32B(3):182-90

Newsletters
Register in our member center today to receive a monthly newsletter with conference coverage updates.
Learn More »
Practice Resources
Learn how to have our conference coverage on your website.
Learn More »
Related News Stories
Maintenance Rituxan® Is Safe for Follicular Lymphoma (7/8/2008)

Gemcitabine, Rituximab, Oxaliplatin, and Pegfilgrastim Active for Relapsed NHL (6/27/2008)

Lumiliximab and FCR Promising for Relapsed CLL (6/26/2008)

Flavopiridol Has Significant Activity in Relapsed Chronic Lymphocytic Leukemia (6/25/2008)

Sprycel® Effective for Patients with Newly Diagnosed CML (6/24/2008)

Tasigna® Effective for Patients with Newly Diagnosed CML (6/24/2008)

Patients with KRAS Mutation Do Not Benefit from EGFR Inhibitors (6/20/2008)

Patients with Lymphoma and CLL Are at Increased Risk of Lung Cancer (6/20/2008)

Does a 10-year 10% Continuous Complete Remission Rate for Myeloma Patients Suggest Cure? (6/19/2008)

Radiation Therapy for Prostate Cancer Increases Incidence of AML (6/18/2008)

Quinamed® + ARA-C Effective for Secondary Acute Myeloid Leukemia (6/17/2008)

Statins May Reduce Acute Graft-versus-host Disease (6/17/2008)

Provigil®, a Eugeroic Agent, Improves Severe Cancer-related Fatigue (6/13/2008)

Results of Treating NHL Patients over the Age of 80 Reported at ASCO (6/12/2008)

Single-dose Carboplatin Confirmed as Effective as Radiation Therapy for Stage I Seminoma (6/12/2008)

Dose-dense Chemotherapy Effective for Localized Ewing’s Sarcoma (6/11/2008)

Mayo Clinic Reports Increasing Use of Mastectomy for Early-stage Breast Cancer (6/11/2008)

Brachytherapy May Be Treatment of Choice for Endometrial Cancer (6/10/2008)

Gemzar® Improves Survival in Early Pancreatic Cancer (6/9/2008)

Addition of Tykerb® to Herceptin® Improves Time to Progression in Herceptin Pre-treated Breast Cancer (6/6/2008)

Addition of Avastin® to Taxotere® Improves Progression-free Survival in Advanced HER2-negative Breast Cancer (6/6/2008)

Nexavar® Delays Progression of Heavily Pre-treated NSCLC (6/6/2008)

Acupuncture Reduces Pain after Neck Dissection (6/6/2008)

VePesid®/Platinol® Remains Standard of Care for Small Cell Lung Cancer (6/6/2008)

Blood Test Shows Promise for Early Detection of Lung Cancer (6/6/2008)

Tykerb® Monotherapy Active in HER2-positive Refractory Inflammatory Breast Cancer (6/6/2008)

CDX-110 Vaccine May Improve Survival in Brain Cancer (6/5/2008)

Sites of Relapse in Breast Cancer May Require Biopsy to Accurately Determine HER2 or Hormone Status (6/5/2008)

Study Confirms Efficacy of Sutent® for Initial Treatment of Metastatic Renal Cell Cancer (6/4/2008)

Conventional Chemotherapy Outperforms Xeloda® in Older Breast Cancer Patients (6/4/2008)




© 1998-2007 CancerConsultants.com  All Rights Reserved.